Video Latest - ecancer

Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neoplasm patients

Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA

11 Dec 2021

Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies

Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA

$Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in pts with relapsed/refractory B-cell malignancies ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )$

11 Dec 2021

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA

11 Dec 2021

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

8 Dec 2021

Post-HSCT management of ALL - Adult ALL perspective

Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain

6 Dec 2021

Latest in diagnostics in EGFR mutated NSCLC

Dr Neal Lindeman - Brigham and Women's Hospital, Boston, USA

3 Dec 2021

The Lancet Commission on women and cancer

Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA

3 Dec 2021

Paediatric ALL perspective

Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy

12 Nov 2021

Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)

Prof Robin Foà - Sapienza University of Rome, Rome, Italy

11 Nov 2021

Practical applications on new data of genetic ALL subtypes

Prof Robin Foà - Sapienza University of Rome, Rome, Italy

10 Nov 2021

Tobacco control in Africa

Dr Mark Parascandola - U.S. National Cancer Institute, Baltimore, USA

10 Nov 2021

High-risk SMM imaging and NDMM treatment

Dr Elena Zamagni - University of Bologna, Bologna, Italy

28 Oct 2021

Video

More from ecancer